Spire Healthcare Group plc (LON:SPI - Get Free Report)'s share price crossed above its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of GBX 190.41 ($2.59) and traded as high as GBX 206.50 ($2.80). Spire Healthcare Group shares last traded at GBX 205.50 ($2.79), with a volume of 682,518 shares traded.
Analyst Ratings Changes
Separately, Deutsche Bank Aktiengesellschaft dropped their price target on shares of Spire Healthcare Group from GBX 320 ($4.35) to GBX 300 ($4.07) and set a "buy" rating on the stock in a research report on Thursday, March 6th.
View Our Latest Stock Analysis on SPI
Spire Healthcare Group Stock Up 0.5%
The firm has a 50-day moving average price of GBX 191.03 and a two-hundred day moving average price of GBX 208.13. The company has a market capitalization of £839.28 million, a P/E ratio of 29.75, a PEG ratio of 1.06 and a beta of 0.96. The company has a quick ratio of 0.74, a current ratio of 0.70 and a debt-to-equity ratio of 62.25.
Spire Healthcare Group (LON:SPI - Get Free Report) last issued its quarterly earnings results on Thursday, March 6th. The company reported GBX 8.80 ($0.12) earnings per share for the quarter. Spire Healthcare Group had a net margin of 1.96% and a return on equity of 3.82%. Equities research analysts anticipate that Spire Healthcare Group plc will post 15.6634747 EPS for the current fiscal year.
Spire Healthcare Group Company Profile
(
Get Free Report)
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.
Featured Articles
Before you consider Spire Healthcare Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Spire Healthcare Group wasn't on the list.
While Spire Healthcare Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for June 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
